AMERIGEN Trademark

Trademark Overview

On Tuesday, March 29, 2016, a trademark application was filed for AMERIGEN with the United States Patent and Trademark Office. The USPTO has given the AMERIGEN trademark a serial number of 86956277. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 2, 2020. This trademark is owned by Amerigen Pharmaceuticals, Ltd.. The AMERIGEN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of hypertension, depression, cardiovascular disease, allergies, neurological disorders, gastro-intestinal disease, urinary incontinence, Parkinson's disease, Alzheimer's disease, oncology, diabetes and metabolic disorders, dermatological disorders, bipolar disorder and schizophrenia, vitamin D deficiency, bleeding disorders, BPH or benign prostatic hyperplasia, erectile dysfunction and pain, women's health issues relating to birth control, menstruation, menopause, breast health and disorders, sexual health and disorders, female reproductive health and disorders, pregnancy and autoimmune diseases
amerigen

General Information

Serial Number86956277
Word MarkAMERIGEN
Filing DateTuesday, March 29, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 2, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 6, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of hypertension, depression, cardiovascular disease, allergies, neurological disorders, gastro-intestinal disease, urinary incontinence, Parkinson's disease, Alzheimer's disease, oncology, diabetes and metabolic disorders, dermatological disorders, bipolar disorder and schizophrenia, vitamin D deficiency, bleeding disorders, BPH or benign prostatic hyperplasia, erectile dysfunction and pain, women's health issues relating to birth control, menstruation, menopause, breast health and disorders, sexual health and disorders, female reproductive health and disorders, pregnancy and autoimmune diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 1, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmerigen Pharmaceuticals, Ltd.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressKY1-1111
KY
Party NameAmerigen Pharmaceuticals, Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressKY1-1111
KY

Trademark Events

Event DateEvent Description
Monday, March 2, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 2, 2020ABANDONMENT - NO USE STATEMENT FILED
Wednesday, January 22, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, July 4, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 3, 2019EXTENSION 5 GRANTED
Monday, July 1, 2019EXTENSION 5 FILED
Wednesday, July 3, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 1, 2019TEAS EXTENSION RECEIVED
Friday, December 14, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 12, 2018EXTENSION 4 GRANTED
Wednesday, December 12, 2018EXTENSION 4 FILED
Wednesday, December 12, 2018TEAS EXTENSION RECEIVED
Thursday, June 7, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 5, 2018EXTENSION 3 GRANTED
Tuesday, June 5, 2018EXTENSION 3 FILED
Tuesday, June 5, 2018TEAS EXTENSION RECEIVED
Tuesday, January 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 5, 2018EXTENSION 2 GRANTED
Friday, January 5, 2018EXTENSION 2 FILED
Friday, January 5, 2018TEAS EXTENSION RECEIVED
Wednesday, July 19, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 17, 2017EXTENSION 1 GRANTED
Monday, July 17, 2017EXTENSION 1 FILED
Monday, July 17, 2017TEAS EXTENSION RECEIVED
Monday, July 17, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 31, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 6, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 6, 2016PUBLISHED FOR OPPOSITION
Wednesday, November 16, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 26, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 19, 2016NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Tuesday, April 19, 2016EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Tuesday, April 19, 2016COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Tuesday, April 19, 2016EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Wednesday, April 13, 2016ASSIGNED TO EXAMINER
Friday, April 1, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, April 1, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

amerigen disorders disease health pain women issues dysfunction benign bleeding prostatic